First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
34 hedge funds and large institutions have $22M invested in First Trust Nasdaq Pharmaceuticals ETF in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
1.38% more ownership
Funds ownership: 50.72% → 52.1% (+1.4%)
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.85M | |
| 2 | +$982K | |
| 3 | +$550K | |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$491K |
| 5 |
EH
Equitable Holdings
New York
|
+$428K |
Top Sellers
| 1 | -$3.03M | |
| 2 | -$882K | |
| 3 | -$701K | |
| 4 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$474K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$224K |